Skip to content

Role of Ayurveda medicines in treating fistula

Efficacy assessment of integrated approach with Aragwadadi Varti in the management of Bhagandara (Low anal fistula ) - A Randomized Active Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/109936
Enrollment
80
Registered
2026-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

None listed

Sponsors

Dr Bhagyashri Patil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients above the age of 18 years and below 70 years irrespective of caste gender religion and socioeconomic status 2 Low anal fistula and subcutaneous fistula (According to Milligan Morgan classification) 3 Intersphincteric and transphincteric fistula (According to Parks classification) 4 St James University Hospital (SJUH) classification I to IV 5 Patients who are willing to enrol in the study by giving written consent

Exclusion criteria

Exclusion criteria: 1 Subjects with secondary fistula like Ulcerative colitis Crohns disease Tuberculosis Hidradenitis Suppurativa Carcinoma of rectum & anal canal 2 Subjects with other systemic illness like uncontrolled hypertension and uncontrolled diabetes mellitus HIV and HBsAg positive subjects 3 Pregnancy and lactating women 4 Subjects having haemoglobin less than 10 gm% 5 Subjects with H/O impaired cardiac renal and hepatic function 6 High anal fistula (According to Milligan Morgan classification High anal and Pelvirectal and Parks classification Supralevator/suprasphincteric and Extrasphincteric)

Design outcomes

Primary

MeasureTime frame
1 Unit cutting time 2 Size of wound and granulation tissue according to Bates jensen wound assessment tool 3 Pain assessed by NPRS scale Timepoint: Baseline day 7 day 14 day 21 day 28

Secondary

MeasureTime frame
Quality of life Assessment ToolTimepoint: Baseline and day 28

Countries

India

Contacts

Public ContactDr Pradeep S Shindhe

KAHERs Shri B M Kankanawadi Ayurveda Mahavidyalaya, Belagavi

pshindhe@gmail.com9986331357

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026